The SERPINC1 gene plays a critical role in the body's anticoagulation system by coding for antithrombin III, a protein that helps regulate blood clot formation. Mutations in the SERPINC1 gene can lead to antithrombin III deficiency, a rare inherited disorder that significantly increases the risk of developing abnormal blood clots. Individuals with this condition are more susceptible to venous thromboembolism, including deep vein thrombosis (DVT) and pulmonary embolism (PE), which can be life-threatening.
To diagnose antithrombin III deficiency and assess the risk of thrombotic events, genetic testing of the SERPINC1 gene can be performed. DNA Labs UAE offers this specialized genetic test, which involves analyzing the DNA to identify mutations in the SERPINC1 gene that are associated with antithrombin III deficiency. The test is crucial for individuals with a personal or family history of abnormal blood clots, as it can help in the early detection and management of the condition.
The cost of the SERPINC1 gene antithrombin III deficiency genetic test at DNA Labs UAE is 4400 AED. The testing process is straightforward, typically requiring only a blood sample from the patient. Results from this test can provide valuable information for developing a personalized treatment and prevention plan, including considerations for anticoagulant therapy and lifestyle adjustments to minimize the risk of thrombosis.
The TGFBR2 Gene Aortic Aneurysm Familial Thoracic Type 3 Genetic Test is a specialized diagnostic procedure aimed at detecting mutations in the TGFBR2 gene, which are implicated in the development of Familial Thoracic Aortic Aneurysm Type 3 (FTAAD). This condition is characterized by the weakening and subsequent enlargement of the thoracic aorta, which can lead to life-threatening aortic dissections or ruptures if left undiagnosed and untreated. Individuals with a family history of thoracic aortic aneurysms are particularly recommended to undergo this genetic testing to assess their risk.
Performed at DNA Labs UAE, a leading facility in genetic diagnostics, this test provides a critical tool for early detection and management of the condition. With a cost of 4400 AED, the test is a worthwhile investment for those at risk, offering them the chance to take preventative measures against potential aortic complications. Early detection through the TGFBR2 genetic test can significantly impact the management approach, including regular monitoring and surgical interventions, to prevent the serious consequences associated with Familial Thoracic Aortic Aneurysms.
The MYH11 Gene Aortic Aneurysm Familial Thoracic Type 4 Genetic Test is a specialized diagnostic procedure aimed at identifying mutations in the MYH11 gene, which are associated with a predisposition to familial thoracic aortic aneurysms. This type of aortic aneurysm is a serious condition where the wall of the thoracic section of the aorta, the major artery carrying blood out of the heart, weakens and can lead to life-threatening complications if not managed properly. The test is particularly crucial for individuals with a family history of this condition, as it can provide vital information for early detection, preventive measures, and tailored treatment strategies.
Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed for specific mutations in the MYH11 gene that have been linked to the development of thoracic aortic aneurysms. The process is designed to be as non-invasive and straightforward as possible, with a focus on providing accurate and reliable results.
The cost of the MYH11 Gene Aortic Aneurysm Familial Thoracic Type 4 Genetic Test is 4400 AED. While the price may seem significant, the value of the information it provides cannot be overstated for those at risk. Early detection and intervention can significantly improve the quality of life and survival rates for individuals predisposed to this condition. This test represents an important step in proactive health management and genetic counseling for affected families.
The "TGFBR1 Gene Aortic Aneurysm Familial Thoracic Type 5 Genetic Test" is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the TGFBR1 gene that are linked to Aortic Aneurysm Familial Thoracic Type 5. This condition is a genetic disorder that predisposes individuals to thoracic aortic aneurysms and dissections, which can lead to life-threatening complications if not diagnosed and managed appropriately. The test, priced at 4400 AED, provides crucial information for the early detection and management of this condition, allowing for timely intervention and personalized treatment plans. By analyzing the specific genetic makeup of the TGFBR1 gene, healthcare professionals can better understand the risk factors associated with the development of thoracic aortic aneurysms in affected families, enabling them to implement preventive measures and monitor the condition closely.
The ACTA2 gene plays a crucial role in the smooth muscle cells that line the aorta, which is the largest artery in the body responsible for carrying blood from the heart to the rest of the body. Mutations in the ACTA2 gene can lead to a condition known as Aortic Aneurysm, Familial Thoracic Type 6. This genetic disorder is characterized by the weakening and abnormal dilation of the aortic wall, which can lead to life-threatening events such as aortic dissection or rupture if not properly managed.
To diagnose this condition and identify individuals at risk, a specific genetic test is available at DNA Labs UAE. This test specifically looks for mutations in the ACTA2 gene that are known to contribute to the development of Aortic Aneurysm, Familial Thoracic Type 6. By identifying these mutations, healthcare providers can better understand an individual's risk for developing this condition and can implement appropriate monitoring and management strategies to prevent serious complications.
The cost of the ACTA2 Gene Aortic Aneurysm Familial Thoracic Type 6 Genetic Test at DNA Labs UAE is 4400 AED. This test is a valuable tool for individuals with a family history of thoracic aortic aneurysms, as it provides critical information that can guide clinical decisions and potentially life-saving interventions.
The MYLK Gene Aortic Aneurysm Familial Thoracic Type 7 Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to detect mutations in the MYLK gene. These mutations are associated with the development of Familial Thoracic Aortic Aneurysm Type 7 (FTAAT7), a hereditary condition that predisposes individuals to thoracic aortic aneurysms. Thoracic aortic aneurysms are serious health conditions where the aorta, the large artery carrying blood from the heart to the rest of the body, becomes abnormally enlarged or dilated, increasing the risk of life-threatening events such as aortic dissection or rupture.
Understanding one's genetic predisposition to this condition is crucial for early detection and management, potentially saving lives through timely medical intervention. The test is particularly recommended for individuals with a family history of thoracic aortic aneurysms or related cardiovascular conditions.
At DNA Labs UAE, the MYLK Gene Aortic Aneurysm Familial Thoracic Type 7 Genetic Test is offered at a cost of 3200 AED. The test involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed for specific mutations in the MYLK gene. Results from this test can provide valuable information for both affected individuals and their family members regarding the risk of developing thoracic aortic aneurysms, facilitating informed decisions about monitoring and preventive strategies.
The PRKG1 gene plays a crucial role in the development of Aortic Aneurysm Familial Thoracic Type 8, a genetic condition characterized by the abnormal enlargement of the aorta, the major artery coming out of the heart. This condition can lead to life-threatening complications such as aortic dissection or rupture. The genetic test for this condition focuses on identifying mutations in the PRKG1 gene, which are indicative of an individual's predisposition to developing this type of aortic aneurysm.
Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, this test is an essential tool for families with a history of thoracic aortic aneurysms. By detecting the presence of specific genetic mutations associated with Aortic Aneurysm Familial Thoracic Type 8, individuals can take proactive steps in managing their health, including regular monitoring and preventive measures to mitigate the risk of serious complications. The test is priced at 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify the genetic markers associated with this condition. Through this testing, at-risk individuals can gain valuable insights into their genetic makeup, empowering them with the information needed to make informed decisions about their health and preventative care.
The MAT2A gene plays a critical role in the development and maintenance of various bodily tissues, including the aorta. Mutations in this gene can lead to familial thoracic aortic aneurysm, a serious condition characterized by the abnormal enlargement of the aorta in the chest area. This can lead to life-threatening complications if not properly managed.
To identify individuals at risk, the MAT2A Related Genetic Test is available at DNA Labs UAE. This specialized test screens for mutations in the MAT2A gene that are associated with familial thoracic aortic aneurysm. By detecting these genetic variations, the test can help in the early diagnosis and management of the condition, potentially preventing severe outcomes.
The cost of the MAT2A Related Genetic Test is 4400 AED. Conducted in the state-of-the-art facilities of DNA Labs UAE, this test provides a crucial tool for individuals with a family history of thoracic aortic aneurysms, enabling them to take timely preventive measures and make informed decisions about their health.
The NOTCH1 Gene Aortic Valve Disease Type 1 Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the NOTCH1 gene, which are linked to the development of Aortic Valve Disease Type 1. This condition is a critical heart defect that affects the valve controlling blood flow from the heart into the aorta, the body's main artery. Mutations in the NOTCH1 gene can lead to a variety of symptoms, ranging from mild to severe heart issues, necessitating early and accurate diagnosis for effective management and treatment planning.
The test is conducted through a comprehensive analysis of the patient's DNA to pinpoint any genetic alterations in the NOTCH1 gene that might predispose them to this specific type of aortic valve disease. By identifying these mutations, healthcare providers can better understand the condition's progression, potential complications, and tailor treatment strategies to the individual's genetic profile.
The cost of the NOTCH1 Gene Aortic Valve Disease Type 1 Genetic Test at DNA Labs UAE is set at 4400 AED. This price reflects the sophisticated nature of the testing process and the invaluable insights it provides into managing and treating aortic valve disease more effectively. Patients considering this test are encouraged to consult with their healthcare provider to understand how the results might impact their treatment plan and to ensure it's the right step in their care journey.
The "SMAD6 Gene Aortic Valve Disease Type 2 Genetic Test" is a specialized diagnostic tool designed to identify mutations in the SMAD6 gene, which are associated with Aortic Valve Disease Type 2 (AVD2). This condition is a critical cardiovascular anomaly that affects the structure and function of the aortic valve, potentially leading to heart failure and other serious complications if left undiagnosed and untreated.
The test involves analyzing the patient's DNA to detect any genetic variations in the SMAD6 gene that could predispose them to AVD2. Early detection through this genetic testing is crucial for the management and treatment of the condition, allowing healthcare providers to implement preventative measures or interventions to mitigate the risk of severe outcomes.
Performed at DNA Labs UAE, a leading facility in genetic diagnostics, the test offers a comprehensive analysis ensuring accuracy and reliability. The cost of the test is set at 4400 AED, reflecting the sophisticated technology and expertise required to conduct this specialized genetic assessment.
By opting for the SMAD6 Gene Aortic Valve Disease Type 2 Genetic Test, individuals at risk can take a proactive step towards understanding their genetic predisposition to AVD2, enabling informed decisions about their health and future medical care.
